Anthelmintic resistance occurs when a heritable genetic change occurs in the parasite's DNA, rendering it insensitive to a previously effective anthelmintic drug. This is a particularly serious problem in helminth parasites of small ruminant farm animals. This is a major threat to the sustainability of modern ruminant livestock production, resulting in reduced productivity, compromised animal health and welfare, and increased greenhouse gas emissions through increased parasitism and farm inputs. However, resistance is not seen as often in the parasitic helminths that affect cattle, compared to sheep. Reasons for this include the fact that cattle receive anthelmintic drugs less frequently than sheep, and the different nature of their faecal pats that could leave different numbers of resistant infective larvae on the pasture. Both
in vitro (egg hatch assay, larval development test, larval motility test,
polymerase chain reaction and
in vivo methods (
fecal egg count reduction test) can be used to detect anthelmintic resistance.[11] Treatment with an antihelmintic drug kills worms whose phenotype renders them susceptible to the drug, but
resistant parasites survive and pass on their "resistance" genes. Resistant varieties accumulate, and treatment failure finally occurs. The ways in which anthelmintics are used have contributed to a major anthelmintic resistance issue worldwide. From the 1950s to the 1980s, new classes of effective and inexpensive anthelmintics were made available every decade, leading to excessive use throughout agriculture and disincentivizing alternative anti-nematodal strategies. Other methods include using a combination of multiple different anthelmintics, and the use of
refugia based strategies. R
efugia refers to the portion of the parasite population not being exposed to anthelmintics. This population is therefore not undergoing selection for resistance. Use of
refugia helps to slow down the speed of evolution of resistance to anthelmintic drugs. Due to the problem of anthelmintic resistance, research into alternatives is continuing, including in the field of
rational drug design. == See also ==